Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein C pseudogene 2 (HNRNPCP2)

Target
HNRNPCP2
Molecular classification
Other, Pseudogene; does not encode a functional protein
01

Overview

Heterogeneous nuclear ribonucleoprotein C pseudogene 2 (HNRNPCP2) is a genomic sequence classified as a pseudogene; it shares sequence similarity with heterogeneous nuclear ribonucleoprotein C genes but does not encode a functional protein. Pseudogenes like HNRNPCP2 are typically remnants of duplicated or otherwise inactivated genes and are not considered biologically active. There is no evidence in current literature or major gene databases that HNRNPCP2 is involved in disease, acts as a therapeutic target, or displays any biological functions apart from sequence homology to its parent gene family[1]. This entry reflects the distinction that HNRNPCP2 is not a functional target—and is thus not suitable for inclusion in structured drug or receptor databases. If the intended target is HNRNPC (the functional protein), it is recommended to use "heterogeneous nuclear ribonucleoprotein C (HNRNPC)" instead[1][3][7].

Other names
HNRNPCP2heterogeneous nuclear ribonucleoprotein C pseudogene 2

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein C pseudogene 2 (HNRNPCP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein C pseudogene 2 (HNRNPCP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call